CAS: 1953133-47-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Giredestrant REF: TM-T11399CAS: 1953133-47-5 | 98.96% - 98.96% | 134.00 €~2,752.00 € | Tue 21 Jan 25 |
 | GDC-9545 REF: 4Z-K-031110CAS: 1953133-47-5 | - - - | To inquire | Tue 28 Jan 25 |
 | Giredestrant REF: 3D-DDD13347CAS: 1953133-47-5 | Min. 95% | To inquire | Tue 04 Mar 25 |
Giredestrant
CAS:1953133-47-5
Giredestrant (GDC-9545) is a potent oral anti-tumor ER antagonist competing with estradiol.
Formula:
C27H31F5N4O
Purity:
98.96% - 98.96%
Color and Shape:
Solid
Molecular weight:
522.55
Ref: TM-T11399
| 1mg | 134.00 € | ||
| 5mg | 270.00 € | ||
| 10mg | 432.00 € | ||
| 25mg | 807.00 € | ||
| 50mg | 1,290.00 € | ||
| 100mg | 2,023.00 € | ||
| 200mg | 2,752.00 € | ||
| 1mL*10mM (DMSO) | 314.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ref: 4Z-K-031110
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 28 Jan 2025
Giredestrant
CAS:1953133-47-5
Giredestrant is a synthetic peptide that can be used as a research tool in pharmacology …
Formula:
C27H31F5N4O
Purity:
Min. 95%
Molecular weight:
522.6 g/mol
Ref: 3D-DDD13347
| 10mg | 927.00 € | ||
| 25mg | 1,421.00 € | ||
| 50mg | 2,274.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
